Bakuchiol treatment increases the population of cytotoxic immune cells (i.e., M1 macrophages and CD8+ T cells) while also decreasing pro-tumor immune cells (i.e., CD3+ T cells, Tregs, and M2 macrophages). The gene discussed is CD8A; the disease is neoplasm.